HeartBeam, Inc.
BEATNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$21.1M | −$19.9M | −$15.3M | −$13.0M | −$2.3M | −$788,000 |
| Net income | −$21.0M | −$19.4M | −$14.6M | −$13.0M | −$4.4M | −$1.1M |
| Total assets | $5.8M | $3.3M | $17.1M | $4.0M | $14.0M | $51,000 |
| Total liabilities | $3.2M | $1.6M | $1.2M | $1.7M | $588,000 | $4.8M |
| Equity | $2.6M | $1.7M | $15.9M | $2.4M | $13.4M | −$4.8M |
| EPS (diluted) | $-0.62 | $-0.73 | $-0.72 | $-1.59 | $-1.03 | $-0.29 |
| Shares out. | 33.7M | 26.3M | 8.2M | 8.0M | 7.8M | 3.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −807.3%
- Return on assets
- −359.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 55.5%
- Debt / equity
- 1.24×
- Book value / share
- $0.08
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −120.3%clean
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 1 good- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Cruickshank TimOfficer — CFO | Apr 16, 2026 | Buy | 31,250 | $0.80 |
| Elfrink WillemDirector | Apr 16, 2026 | Buy | 187,500 | $0.80 |
| Jaff Michael RDirector | Apr 16, 2026 | Buy | 31,250 | $0.80 |
| Vajdic BranislavDirector | Apr 16, 2026 | Buy | 31,250 | $0.80 |
| Ferrari RichardDirector | Apr 16, 2026 | Buy | 62,500 | $0.80 |
| Eno Robert PaulOfficer — President | Apr 16, 2026 | Buy | 12,500 | $0.80 |
| Ortigas-Wedekind MargaDirector | Apr 16, 2026 | Buy | 25,000 | $0.80 |
| Strome Mark EDirector | Apr 16, 2026 | Buy | 750,000 | $0.80 |
| Ferrari RichardDirector | Feb 9, 2026 | Grant | 50,000 | $0.00 |
| Jaff Michael RDirector | Feb 9, 2026 | Grant | 20,689 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.6M | 3.0 | -11.0% |
| Apr 30, 2026 | 2.9M | 1.8 | -5.6% |
| Apr 15, 2026 | 3.1M | 2.6 | -2.0% |
| Mar 31, 2026 | 3.1M | 6.1 | -22.8% |
| Mar 13, 2026 | 4.1M | 1.0 | +112.3% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Other material eventApr 16, 2026
- Other material eventNov 21, 2025
- Shareholder voteJul 16, 2025
- Director / officer change · Regulation FD disclosureMay 5, 2025
- Changed auditorApr 25, 2025
- Other material eventFeb 26, 2025
- Entered a material agreement · Other material eventFeb 18, 2025
- Director / officer change · Regulation FD disclosureOct 23, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QMay 13, 2026
- 4/AApr 24, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 4Apr 16, 2026
- 8-KCURRENT REPORTApr 16, 2026
- 424B5PROSPECTUS SUPPLEMENTApr 16, 2026
- 424B5PROSPECTUS SUPPLEMENTApr 14, 2026
- 4Mar 23, 2026
- 4Mar 23, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.